Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
IMMUCELL CORP /DE/ amended First Amendment to Economic Recovery Loan Program Loan Agreement with Finance Authority of Maine valued at amends the FAME Loan Agreement to remove any restrictions on the Company’s ability to issue equity s (effective 2024-04-08).
- Action
- amendment
- Agreement
- credit facility
- Counterparty
- Finance Authority of Maine
- Value
- amends the FAME Loan Agreement to remove any restrictions on the Company’s ability to issue equity s
- Effective
- 2024-04-08
Exact text from the filing
In connection with entering into the Sales Agreement, on April 8, 2024, the Company entered into an amendment (the "First Amendment") to the Company's Economic Recovery Loan Program Loan Agreement, by and between the Company and the Finance Authority of Maine dated July 17, 2023 (the "FAME Loan Agreement").
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
IMMUCELL CORP /DE/ entered into At The Market Offering Agreement with Craig-Hallum Capital Group LLC valued at up to $11,000,000 of shares of common stock (effective 2024-04-09).
- Action
- entry
- Agreement
- atm program
- Counterparty
- Craig-Hallum Capital Group LLC
- Value
- up to $11,000,000 of shares of common stock
- Effective
- 2024-04-09
Exact text from the filing
On April 9, 2024, ImmuCell Corporation (the “Company”) entered into an At The Market Offering Agreement (the “Sales Agreement”) with Craig-Hallum Capital Group LLC (the “Sales Agent”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agent, up to $11,000,000 of shares of its common stock, par value $0.10 per share (the “Common Stock”).
View on SEC.gov